Probing the defect nanostructure of helium and proton tracks in LiF:Mg,Ti using optical absorption: Implications to track structure theory calculations of heavy charged particle relative efficiency
“…Irradiations at SARAF were carried out on TLD-100 samples at a fluence of 1.9 × 10 11 protons /cm 2 at beam energy of 1.37 MeV, as part of a series of irradiations at several facilities using different beam particles and energies. This study yielded important insights regarding the treatment of HCP response in TST, and is described in detail in [109].…”
Section: Radiation Dosimeters Response To Protonsmentioning
The Soreq Applied Research Accelerator Facility (SARAF) is under construction in the Soreq Nuclear Research Center at Yavne, Israel. When completed at the beginning of the next decade, SARAF will be a user facility for basic and applied nuclear physics, based on a 40 MeV, 5 mA CW proton/deuteron superconducting linear accelerator. Phase I of SARAF (SARAF-I, 4 MeV, 2mA CW protons, 5 MeV 1mA CW deuterons) is already in operation, generating scientific results in several fields of interest. The main ongoing program at SARAF-I is the production of 30 keV neutrons and measurement of Maxwellian Averaged Cross Sections (MACS), important for the astrophysical s-process. The world leading Maxwellian epithermal neutron yield at SARAF-I (5×10 10 epithermal neutrons/sec), generated by a novel Liquid-Lithium Target (LiLiT), enables improved precision of known MACSs, and new measurements of lowabundance and radioactive isotopes. Research plans for SARAF-II span several disciplines: Precision studies of beyond-Standard-Model effects by trapping light exotic radioisotopes, such as 6 He, 8 Li and 18,19,23 Ne, in unprecedented amounts (including meaningful studies already at SARAF-I); extended nuclear astrophysics research with higher energy neutrons, including generation and studies of exotic neutron-rich isotopes relevant to the rapid (r-) process; nuclear structure of exotic isotopes; high energy neutron cross sections for basic nuclear physics and material science research, including neutron induced radiation damage; neutron based imaging and therapy; and novel radiopharmaceuticals development and production.
“…Irradiations at SARAF were carried out on TLD-100 samples at a fluence of 1.9 × 10 11 protons /cm 2 at beam energy of 1.37 MeV, as part of a series of irradiations at several facilities using different beam particles and energies. This study yielded important insights regarding the treatment of HCP response in TST, and is described in detail in [109].…”
Section: Radiation Dosimeters Response To Protonsmentioning
The Soreq Applied Research Accelerator Facility (SARAF) is under construction in the Soreq Nuclear Research Center at Yavne, Israel. When completed at the beginning of the next decade, SARAF will be a user facility for basic and applied nuclear physics, based on a 40 MeV, 5 mA CW proton/deuteron superconducting linear accelerator. Phase I of SARAF (SARAF-I, 4 MeV, 2mA CW protons, 5 MeV 1mA CW deuterons) is already in operation, generating scientific results in several fields of interest. The main ongoing program at SARAF-I is the production of 30 keV neutrons and measurement of Maxwellian Averaged Cross Sections (MACS), important for the astrophysical s-process. The world leading Maxwellian epithermal neutron yield at SARAF-I (5×10 10 epithermal neutrons/sec), generated by a novel Liquid-Lithium Target (LiLiT), enables improved precision of known MACSs, and new measurements of lowabundance and radioactive isotopes. Research plans for SARAF-II span several disciplines: Precision studies of beyond-Standard-Model effects by trapping light exotic radioisotopes, such as 6 He, 8 Li and 18,19,23 Ne, in unprecedented amounts (including meaningful studies already at SARAF-I); extended nuclear astrophysics research with higher energy neutrons, including generation and studies of exotic neutron-rich isotopes relevant to the rapid (r-) process; nuclear structure of exotic isotopes; high energy neutron cross sections for basic nuclear physics and material science research, including neutron induced radiation damage; neutron based imaging and therapy; and novel radiopharmaceuticals development and production.
“…Several irradiations of TLD dosimetric crystals were performed after establishing the method. The results of these measurements are included in [34].…”
Phase I of the SARAF superconducting RF linac is under operation at the Soreq Nuclear Research Center. The present status of Phase I main components is reported, as well as, the beam operation experience accumulated in 2013-2014. The latter include acceleration of a 2 mA and 1.6 mA CW proton beams at energies of 2 MeV and 3.9 MeV correspondingly and 1 mA pulsed, duty cycle of few %, deuteron beams up to 5.6 MeV. The recent experiments include operation of intense CW proton beams on the liquid lithium target.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.